Conglin Liu

Conglin Liu is the Translational Medicine Lead at Sanofi, where they develop and integrate translational medicine plans for clinical studies in the immunology and inflammation therapeutic area. They hold a Ph.D. in Cardiovascular Disease and Cell Biology from Harvard Medical School and have extensive experience in studying vascular inflammation's role in cardiovascular diseases. Previously, Conglin served as a postdoctoral research fellow at Brigham and Women's Hospital and as a joint Ph.D. student at Harvard, focusing on the pathogenesis of atherosclerosis and abdominal aortic aneurysms. Before their research career, they practiced as a resident physician at The First Affiliated Hospital of Zhengzhou University, where they treated a significant number of patients and supervised graduate students.